|Company name||Acadia Healthcare Company, Inc.|
NEW YORK, May 13, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Acadia Healthcare Company, Inc. (NYSE: ACHC).
On October 10, 2018 a complaint was filed alleging that between April 30, 2014 and November 15, 2018, defendants made materially false and misleading statements regarding Acadia’s business and operations, including by falsely stating that the quality of Acadia’s U.K. operations gave it a competitive strength that would drive future growth and profitability, and by issuing false and misleading guidance regarding the company’s actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization and earnings per share.
If you purchased or otherwise acquired Acadia shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.